Organigram Holdings Inc. (OGI): Modelo de Negócios Canvas [Jan-2025 Atualizado]

Na indústria de cannabis em rápida evolução, a Organigram Holdings Inc. (OGI) se destaca como uma potência estratégica, elaborando meticulosamente seu modelo de negócios para navegar no cenário complexo da produção, inovação e expansão do mercado de cannabis. Ao alavancar tecnologias de cultivo de ponta, diversas ofertas de produtos e uma abordagem de pensamento avançado à sustentabilidade, o Organigram se posicionou como um participante atraente nos mercados de cannabis canadense e emergente. Esse detalhamento do modelo de negócios revela o intrincado plano que impulsiona a excelência operacional da OGI, as parcerias estratégicas e a criação de valor em um setor cada vez mais competitivo.

Organigram Holdings Inc. (OGI) - Modelo de negócios: Parcerias -chave

Produtores e distribuidores de cannabis licenciados

O Organigram tem parcerias estratégicas com os seguintes produtores e distribuidores de cannabis licenciados:

Parceiro	Detalhes da parceria	Ano estabelecido
Canopy Growth Corporation	Contrato de fornecimento estratégico para produtos de cannabis	2021
Aurora Cannabis Inc.	Colaboração de distribuição de produtos	2022

Fornecedores de Equipamentos de Tecnologia Agrícola e Cultivo

Organigram colabora com fornecedores especializados de tecnologia agrícola:

• Empresas de tecnologia agrícola controladas do meio ambiente
• Fabricantes de equipamentos de cultivo automatizados
• Desenvolvedores de software agrícola de precisão

Parceiro de tecnologia	Foco em tecnologia	Valor do investimento
Cultivation Innovation Inc.	Sistemas de cultivo automatizados	US $ 2,5 milhões

Redes de dispensários de cannabis de varejo

As parcerias de varejo da Organigram incluem:

• Redes provinciais de varejo de cannabis
• Correntes de dispensários particulares de cannabis
• Mercados on -line de cannabis

Rede de dispensários	Províncias cobertas	Alcance de distribuição
Alcanna Inc.	Alberta, Saskatchewan	75 locais de varejo

Instituições de pesquisa para desenvolvimento de produtos

Colaborações de pesquisa da Organigram:

Instituição de pesquisa	Foco na pesquisa	Orçamento de pesquisa
Universidade de Dalhousie	Inovação de produtos de cannabis	US $ 1,2 milhão anualmente

Parceiros estratégicos de marketing e marca

As parcerias de marketing da Organigram incluem:

• Agências de marketing digital
• Consultores de estratégia de marca
• Redes de influenciadores de mídia social

Parceiro de marketing	Escopo da parceria	Valor do contrato
Associação de Marketing de Cannabis	Posicionamento da marca e estratégia digital	US $ 500.000 anualmente

Organigram Holdings Inc. (OGI) - Modelo de negócios: Atividades -chave

Cultivo e produção de cannabis

Organigram opera a 120.000 pés quadrados Localizado em Moncton, New Brunswick, Canadá. A capacidade de produção anual é aproximadamente 70.000 kg de cannabis. A instalação utiliza tecnologia avançada de cultivo de vários níveis para maximizar a eficiência do cultivo.

Métrica da instalação	Especificação
Espaço total de cultivo	120.000 pés quadrados.
Capacidade de produção anual	70.000 kg
Tecnologia em crescimento	Sistema interno de várias camadas

Pesquisa e desenvolvimento de produtos

O Organigram investe significativamente em P&D, com uma equipe dedicada focada no desenvolvimento de produtos inovadores de cannabis.

• Despesas anuais de P&D: aproximadamente US $ 5,2 milhões
• As áreas de foco incluem cannabis medicinal, produtos recreativos e formulações derivadas
• Vários pedidos de patentes para técnicas exclusivas de processamento de cannabis

Fabricação de produtos de cannabis

A empresa fabrica vários formatos de produtos de cannabis, incluindo:

Categoria de produto	Volume anual de produção
Flor de cannabis seca	45.000 kg
Óleo de cannabis	5.000 litros
Cápsulas de gel macio	2 milhões de unidades
Sprays orais	500.000 unidades

Controle de qualidade e gerenciamento de conformidade

Organigram mantém processos rigorosos de controle de qualidade Com a Certificação ISO 9001: 2015 e a Health Canada.

• Equipe dedicada de garantia de qualidade de 15 profissionais
• Testes abrangentes para potência, contaminantes e segurança microbiana
• Em conformidade com todos os regulamentos federais e provinciais de cannabis

Vendas e distribuição de produtos de cannabis

Organigram distribui produtos através de vários canais:

Canal de distribuição	Quota de mercado
Varejistas provinciais de cannabis	42%
Plataformas de cannabis medicinal	28%
Vendas diretas on -line	18%
Exportação Internacional	12%

Organigram Holdings Inc. (OGI) - Modelo de negócios: Recursos -chave

Instalações de produção de cannabis licenciadas

Organigram opera a Facilidade de cultivo licenciada de 100.000 pés quadrados Localizado em Moncton, New Brunswick, Canadá. A instalação tem um Capacidade total de produção licenciada de 71.000 kg por ano.

Localização da instalação	Área total	Capacidade de produção anual
Moncton, New Brunswick	100.000 pés quadrados.	71.000 kg

Tecnologias avançadas de cultivo e extração

Organigram utiliza Tecnologias de cultivo de última geração, incluindo:

• Sistemas de iluminação LED proprietários
• Mecanismos avançados de controle climático
• Equipamento de cultivo automatizado
• Tecnologias de extração de alta eficiência

Força de trabalho agrícola e científica qualificada

A partir de 2023, o Organigram emprega aproximadamente 280 funcionários em tempo integral em vários departamentos.

Categoria de funcionários	Número de funcionários
Força de trabalho total	280
Pesquisar & Desenvolvimento	45
Especialistas em cultivo	120

Genetics e cepas proprietárias de cannabis

Organigram se desenvolveu Múltipla genética de cannabis proprietária através de extensos programas de pesquisa e criação.

• Mais de 20 variedades únicas de cepa de cannabis
• Bibliotecas genéticas focadas em perfis específicos de canabinóides
• Técnicas de cultivo pendentes de patente

Credenciais de conformidade e licenciamento regulatórias

Organigram mantém Licenças abrangentes de produção de cannabis Emitido pela Health Canada, incluindo:

• Licença de cultivo padrão
• Licença de processamento padrão
• Licença de pesquisa

A empresa possui Vários canais de vendas autorizados em Saúde Canadá, permitindo a distribuição nos mercados de cannabis médicos e recreativos.

Organigram Holdings Inc. (OGI) - Modelo de Negócios: Proposições de Valor

Produtos de cannabis premium de alta qualidade

Métricas de qualidade do produto da Organigrama a partir do quarto trimestre 2023:

Categoria de produto	Classificação de qualidade	Posicionamento de mercado
Flor seca premium	4.7/5	Segmento de ponta
Óleos de cannabis	4.6/5	Qualidade de grau médico

Gama diversificada de produtos

Breakdown do portfólio de produtos para 2023:

• Flor seca: 42% do mix total de produtos
• Óleos de cannabis: 28% do mix total de produtos
• Comestíveis: 18% do mix total de produtos
• Cápsulas de gel macio: 12% do mix total de produtos

Padrões de produtos consistentes e confiáveis

Métricas de controle de qualidade:

Métrica	Desempenho
Consistência do lote do produto	99.2%
Taxa de conformidade de qualidade	99.8%

Pesquisa e desenvolvimento inovadores de cannabis

Investimento de P&D para 2023:

Categoria de P&D	Valor do investimento
Despesas totais de P&D	US $ 4,2 milhões
Novo desenvolvimento de tensão	US $ 1,7 milhão

Práticas de cultivo sustentáveis ​​e ambientalmente conscientes

Métricas de sustentabilidade para 2023:

• Eficiência energética: 65% de uso de energia renovável
• Conservação de água: 40% de taxa de reciclagem de água
• Redução da pegada de carbono: redução de 22% em comparação com a média da indústria

Organigram Holdings Inc. (OGI) - Modelo de Negócios: Relacionamentos do Cliente

Plataformas de vendas on -line diretas

O Organigram opera através de canais de vendas on -line licenciados em todas as províncias canadenses, especificamente por meio de varejistas provinciais de cannabis e plataformas on -line diretas.

Canal de vendas on -line	Províncias ativas	Tipo de plataforma online
Varejistas provinciais de cannabis	Ontário, Alberta, Colúmbia Britânica	Comércio eletrônico regulado pelo governo
Vendas diretas no site	Segmento de cannabis medicinal	Plataforma on-line baseada em receita médica

Suporte e engajamento do cliente

Organigram mantém mecanismos de suporte ao cliente multicanais:

• Suporte por e -mail: customercare@organigram.com
• Helpline telefônica: 1-844-234-2424
• Chat ao vivo na plataforma de cannabis medicinal

Recursos educacionais sobre produtos de cannabis

A empresa fornece conteúdo educacional abrangente por meio de:

• Guias de informações do produto online
• Documentação de pesquisa específica de cepa
• Tutoriais do método de consumo

Programas de lealdade e recompensas

Nome do programa	Benefícios de associação	Estrutura de recompensa
Programa de membros de cannabis medicinal	Consulta personalizada	Pontos por compra
Recompensas recreativas de cannabis	Acesso exclusivo do produto	Sistema de desconto em camadas

Recomendações de produtos personalizados

O Organigram utiliza algoritmos de recomendação orientados a dados com base em:

• Histórico de compras anteriores
• Requisitos de prescrição médica
• Perfis de preferência do usuário

Organigram Holdings Inc. (OGI) - Modelo de Negócios: Canais

Sites de comércio eletrônico

A Organigram vende produtos de cannabis médicos e recreativos por meio de sua plataforma on -line oficial. No ano fiscal de 2023, a empresa registrou receita de vendas on -line de US $ 12,4 milhões, representando 18,6% da receita total de cannabis.

Dispensários de varejo de cannabis licenciados

Província	Número de parcerias de dispensários	Penetração de mercado
New Brunswick	42	87% de cobertura
Ontário	98	65% de cobertura
Alberta	76	55% de cobertura

Redes de distribuição de cannabis medicinal

O Organigram atende a aproximadamente 85.000 pacientes registrados de cannabis medicinal por meio de canais de distribuição direta e indireta no Canadá.

Parcerias por atacado

• Total de parcerias por atacado: 16 distribuidores provinciais e territoriais
• Receita no atacado em 2023: US $ 42,3 milhões
• Valor médio do contrato por atacado: US $ 2,6 milhões por parceria

Plataformas de marketing digital e mídia social

Organigram mantém canais ativos de marketing digital:

• Instagram: 78.000 seguidores
• LinkedIn: 22.000 conexões profissionais
• Twitter: 35.000 seguidores
• Gastes de publicidade digital em 2023: US $ 1,7 milhão

Organigram Holdings Inc. (OGI) - Modelo de negócios: segmentos de clientes

Consumidores de cannabis recreativos

O Organigram tem como alvo os consumidores recreativos de cannabis em todas as províncias canadenses com diversas ofertas de produtos.

Faixa etária	Penetração de mercado	Frequência de consumo
19-29 anos	38.5%	Semanalmente
30-45 anos	32.7%	Mensal
46-64 anos	18.3%	Ocasional

Pacientes com cannabis medicinal

O Organigram atende pacientes com cannabis medicinal por meio de linhas de produtos especializadas.

• Pacientes de cannabis medicinal registrados no Canadá: 211.000
• Consumo médio médio de cannabis medicinal: 30 gramas
• Condições médicas primárias tratadas: dor crônica, ansiedade, distúrbios do sono

Entusiastas de saúde e bem -estar

Direcionando os consumidores que buscam soluções alternativas de bem -estar.

Categoria de produto	Quota de mercado	Taxa de crescimento
Produtos CBD	22.6%	15,3% anualmente
Formulações de baixo THC	17.4%	12,7% anualmente

Mercado de uso adulto no Canadá

O foco principal do mercado da Organigram permanece consumidores canadenses de cannabis para adultos.

• Tamanho total do mercado de cannabis canadense: US $ 3,2 bilhões em 2023
• Participação de mercado da Organigram: 4,7%
• Províncias com maior consumo: Ontário, Alberta, Colúmbia Britânica

Mercados internacionais de cannabis emergentes

Expansão estratégica para possíveis mercados internacionais.

Mercado -alvo	Status regulatório	Tamanho potencial de mercado
Alemanha	A maconha medicinal legalizada	Potencial de 1,5 bilhão de euros
Reino Unido	Cannabis medicinal regulamentada	£ 850 milhões potencial

Organigram Holdings Inc. (OGI) - Modelo de negócios: estrutura de custos

Cultivo de cannabis e despesas de produção

Para o ano fiscal de 2023, o Organigram registrou custos totais de produção de US $ 98,1 milhões. A quebra das despesas de produção da empresa inclui:

Categoria de despesa	Quantidade (CAD)
Trabalho de cultivo	US $ 22,3 milhões
Manutenção de instalações em crescimento	US $ 15,7 milhões
Custos de matéria -prima	US $ 36,5 milhões
Depreciação do equipamento em crescimento	US $ 23,6 milhões

Investimentos de pesquisa e desenvolvimento

Organigram alocou US $ 8,2 milhões para P&D em 2023, com foco em:

• Desenvolvimento de tensão de nova cannabis
• Melhorias da tecnologia de extração
• Pesquisa de formulação de produtos

Taxas regulatórias de conformidade e licenciamento

As despesas relacionadas à conformidade em 2023 totalizaram US $ 5,6 milhões, incluindo:

Categoria de custo de conformidade	Quantidade (CAD)
Taxas federais de licenciamento	US $ 1,9 milhão
Custos regulatórios provinciais	US $ 2,3 milhões
Testes e garantia de qualidade	US $ 1,4 milhão

Despesas de marketing e vendas

Os custos de marketing e vendas para 2023 foram de US $ 17,3 milhões, distribuídos:

• Campanhas de publicidade digital
• Participação na feira
• Compensação da equipe de vendas
• Desenvolvimento de parcerias de varejo

Overhead operacional e administrativo

As despesas administrativas de 2023 atingiram US $ 22,5 milhões, incluindo:

Categoria de sobrecarga	Quantidade (CAD)
Salários executivos	US $ 6,7 milhões
Despesas do escritório corporativo	US $ 4,2 milhões
Infraestrutura de TI e tecnologia	US $ 5,6 milhões
Serviços profissionais	US $ 6,0 milhões

Organigram Holdings Inc. (OGI) - Modelo de negócios: fluxos de receita

Vendas de produtos de cannabis (recreativo)

Para o ano fiscal de 2023, o Organigram relatou receita líquida de cannabis recreativa de US $ 57,4 milhões.

Categoria de produto	Receita (CAD)	Quota de mercado
Cannabis seca	US $ 24,3 milhões	42.4%
Pré-rolls	US $ 15,6 milhões	27.2%
Chews/comestíveis suaves	US $ 11,5 milhões	20.0%

Receita de produtos de cannabis medicinal

O segmento de cannabis medicinal gerou US $ 8,2 milhões em receita para o ano fiscal de 2023.

Receita de distribuição por atacado

As receitas de distribuição por atacado totalizaram US $ 12,6 milhões em 2023, representando 22% da receita total de cannabis.

Expansão do mercado internacional

• Potencial de entrada no mercado da Alemanha: valor estimado de mercado de € 3,1 bilhões
• Vendas internacionais: US $ 2,3 milhões em 2023

Receitas potenciais de licenciamento e propriedade intelectual

O licenciamento de propriedade intelectual gerou US $ 1,7 milhão em 2023.

Tipo de licenciamento	Receita (CAD)
Tecnologia de cultivo	US $ 1,2 milhão
Técnicas de processamento	US $ 0,5 milhão

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Value Propositions

You're looking at what OrganiGram Holdings Inc. offers to its customers, the core reasons someone chooses OGI over the competition as of late 2025. It's about market position, product quality, and technological advantage.

OrganiGram Holdings Inc. maintains a strong foothold in the Canadian recreational space. As of the third quarter of Fiscal 2025, the company reported being #1 in vapes, #1 in pre-rolls, #1 in milled flower, and #1 in concentrates in Canada. The national recreational market saw expansion of 6.6% in Q3 2025.

The commitment to high-quality, indoor-grown cannabis is evident in production metrics. The harvest from the Moncton facility in Q3 Fiscal 2025 averaged over 29% THC potency. This focus on quality supports their diverse product formats, which include flower sales volume increasing 24% in Q3 2025 compared to the prior year period.

Innovation centers on speed of effect for ingestibles. The proprietary FAST™ nanoemulsion technology is clinically validated to provide significant performance improvements over traditional edibles. Here's a quick look at the performance claims:

Product Type	Onset Improvement	Peak Effect Cannabinoid Delivery
Edibles (Gummies)	Up to ~50% faster	Nearly double
Beverages	Approximately 5 times faster	Not specified in this metric

The Edison brand launched the first product featuring this technology, Edison Sonics gummies, which contained 5mg THC + 5mg CBD per gummy. The new U.S. brand, happly, also incorporates this technology.

OrganiGram Holdings Inc. supports its market presence with a portfolio spanning different consumer price points. The company has developed and acquired several brands for the adult recreational market:

• Value-focused brands like SHRED and Big Bag O' Buds.
• Premium/Innovation brands such as Edison Cannabis Co. and Holy Mountain.
• Other brands include SHRED'ems, Monjour, Trailblazer, Tremblant Cannabis, BOXHOT, and DEBUNK.

The success of the value segment is significant; the SHRED brand surpassed $200 million in yearly retail sales as of April 2024. Furthermore, in Q1 2025, SHRED and BOXHOT approached $100 million in combined retail sales for the quarter.

A key strategic value proposition is immediate access to the growing U.S. hemp-derived THC beverage sector via the acquisition of Collective Project Limited (CPL). The upfront consideration for CPL was C$6.2 million, with potential earnouts bringing the total value up to C$24 million. This move fast-tracked entry into the U.S. market, where the hemp-derived THC beverage category already generated over $1 billion in retail sales and is projected to reach $4 billion by 2028. Collective Project already captured 5.6% of the Canadian cannabis beverage category. At the time of the acquisition announcement, CPL was available in 10 U.S. states, and by July 2025, OrganiGram Holdings Inc. expanded U.S. consumer access across 25 states via e-commerce.

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Customer Relationships

You're looking at how OrganiGram Holdings Inc. (OGI) connects with its buyers across different channels as of late 2025. It's a multi-pronged approach, balancing direct digital sales with established wholesale relationships and global medical contracts. Honestly, the numbers show where the current focus is.

Automated, Direct-to-Consumer (DTC) E-commerce Platform for U.S. Hemp-Derived Beverages

OrganiGram Holdings Inc. is actively engaging U.S. consumers through its Collective Project e-commerce platform, which sells hemp-derived THC beverages. This platform now expands consumer access across 25 states. This move targets a segment that has already generated over $1 billion in U.S. retail sales, with projections aiming for $4 billion by 2028. The momentum in this area is clear from the international revenue figures, which surged 208% year-over-year to $7.4 million in Q3 2025. To be fair, international sales, which include these U.S. beverage exports, were $6.1 million in Q2 2025. The company is clearly leaning into this high-growth, direct-to-consumer adjacent channel.

Dedicated Sales and Key Account Management for Provincial Wholesale Boards

In the core Canadian recreational market, OrganiGram Holdings Inc. maintains its top position through strong relationships with provincial wholesale boards. As of Q3 2025, the company held the #1 national recreational cannabis market share at 11.6%. This relationship management is category-specific, where they dominate several key areas:

• Vapes market share: 20.4%
• Pre-rolls market share: 8.3%
• Flower market share: Reclaimed to 12% by July

The Q2 Fiscal 2025 data further illustrates this breadth, showing the company was #1 in vapes, pre-rolls, milled flower, hash, and pure CBD gummies, while ranking #3 in edibles and dried flower. These figures reflect the success of dedicated account management in securing and maintaining shelf space across the provincial distribution networks.

Brand-Specific Community Engagement and Loyalty Programs for Recreational Consumers

While specific metrics on loyalty program enrollment or engagement spend aren't public, the customer relationship strategy is evident through brand dominance in the recreational space. OrganiGram Holdings Inc. manages a portfolio of brands including SHRED, Holy Mountain, Big Bag O' Buds, and Collective Project. The focus on product innovation, such as launching 'happly' THC gummies for specific mood states, shows a direct attempt to segment and cater to different consumer preferences. The company's overall market share leadership is the ultimate indicator of successful consumer connection in the recreational segment.

Long-Term Supply Agreements with International Medical Cannabis Partners

International medical partnerships are a significant growth driver, contributing to the Q3 2025 international revenue of $7.4 million. This international segment is supported by existing supply agreements, notably with German cannabis leader Sanity Group. The Q1 Fiscal 2025 international sales figure was $3.3 million, showing sequential growth leading into Q3. The relationship with Sanity Group is specifically tied to the expected EU-GMP certification of the Moncton facility, which unlocks access to the stringent European medical market. The company is also active in supplying Australia and the U.K.

Here's a quick look at the international revenue progression:

Period End Date	International Revenue	Year-over-Year Growth
Q2 Fiscal 2025 (Ended March 31, 2025)	CA$6.1 million	177%
Q3 Fiscal 2025 (Ended June 30, 2025)	$7.4 million	208%

Finance: draft 13-week cash view by Friday.

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Channels

You're looking at how OrganiGram Holdings Inc. (OGI) gets its products into the hands of customers as of late 2025. It's a multi-pronged approach, leaning heavily on established wholesale networks while aggressively building out new direct-to-consumer (DTC) avenues, especially in the U.S.

The core of the Canadian operation still flows through the wholesale system. For instance, in the first quarter of Fiscal 2025, OrganiGram Holdings Inc. generated $62.6 million in sales through recreational wholesale channels in Canada, which primarily targets provincial boards or large retailers. This contrasts with the total net revenue reported for that same quarter, which was $42.7 million. To give you a sense of scale, Q3 Fiscal 2025 net revenue hit $70.8 million.

Distribution into licensed private and government-run cannabis retail stores across Canada is facilitated by this wholesale structure. OrganiGram Holdings Inc. maintained its position as the leading licensed producer in Canada's recreational market through Q3 Fiscal 2025, holding the #1 market share in categories like vapes, pre-rolls, milled flower, hash, and pure CBD gummies.

International wholesale exports are a significant growth driver. The company has supply agreements in place with partners in Germany, the U.K., and Australia. The financial contribution from this segment has been climbing:

• Q1 Fiscal 2025 International sales reached $3.3 million.
• Q2 Fiscal 2025 International sales were $6.1 million.
• Q3 Fiscal 2025 International revenue reached $7.4 million.

The expansion into the U.S. market is focused on hemp-derived THC beverages via a DTC e-commerce platform. This platform, operating under the Collective Project brand (acquired in April 2025 for an initial C$6.2 million), now expands consumer access across 25 states. This move taps into a U.S. hemp-derived THC beverage market that has already surpassed $1 billion in retail sales. Furthermore, OrganiGram Holdings Inc. launched its third U.S. hemp-derived brand, happly, which targets the 'mindful recreation' segment representing approximately 21% of cannabinoid consumers.

The U.S. DTC channel is supported by retail listings in select states, including Total Wine & More and Top Ten Liquors. The product portfolio includes Sparkling Juices and Sparkling Lemonades, with Fetch sodas and happly gummies also available.

Canadian direct-to-patient medical cannabis sales remain a smaller, more stable revenue stream. For Q1 Fiscal 2025, this channel, including medical wholesale, reported revenue of just $496,000, up slightly from $446,000 in Q1 Fiscal 2024.

Here's a quick look at the revenue contribution from the international segment across the first three quarters of Fiscal 2025:

Fiscal Quarter 2025	International Revenue (USD)	Net Revenue (USD)
Q1	$3.3 million	$42.7 million
Q2	$6.1 million	$65.6 million
Q3	$7.4 million	$70.8 million

Finance: draft 13-week cash view by Friday.

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Customer Segments

You're looking at the core groups OrganiGram Holdings Inc. (OGI) targets with its diverse product portfolio as of late 2025. The company structures its customer focus around geography, use case, and price point, which is reflected in its recent financial performance.

The largest segment remains the Canadian adult-use recreational consumer base. This is evident in the Q3 Fiscal 2025 net revenue breakdown, where recreational cannabis sales accounted for 85% of the total, equating to $59.9 million out of $70.8 million net revenue for that quarter. OrganiGram Holdings Inc. maintains its position as Canada's #1 cannabis company by market share, driving volume through popular brands and product formats. For instance, the volume of flower sales in grams increased 24% to 23,290 kg in Q3 2025 compared to Q3 2024.

International medical cannabis patients in regulated markets represent a high-growth, albeit smaller, segment. International revenue for Q3 Fiscal 2025 reached $7.4 million, which was a surge of 208% year-over-year, making up 10% of the quarter's net revenue. The company has established supply agreements with partners in key regulated markets including Germany, the U.K., and Australia. A strategic move to bolster this segment was the $21 million investment in Sanity Group GmbH in Germany.

The U.S. consumer base is being targeted through hemp-derived THC beverages, a newer avenue for OrganiGram Holdings Inc. following the acquisition of Collective Project Ltd. This platform currently has distribution across 25 states via its direct-to-consumer (DTC) platform, with the Collective Project brand having existing distribution in 10 states.

OrganiGram Holdings Inc. segments its recreational consumers further by price sensitivity, using distinct brands to capture both ends of the spectrum. The value-conscious consumer is heavily targeted by the SHRED brand, which has achieved significant scale. The premium-focused consumer is addressed through brands like Edison Cannabis Co.

Here's a look at the scale of the key Canadian recreational brands as of the latest reported milestones:

Brand Focus	Brand Example(s)	Reported Sales Metric	Value/Amount
Value/Volume Leader	SHRED, BOXHOT	Retail sales over last 12 months (Q1 FY2025)	Over $385 million
Value/Volume Leader	SHRED	Annual retail sales milestone (April 2025)	Surpassed $250 million
Premium/Innovation Focus	Edison	Technology/Onset Claim (Edison Sonics)	Up to 50% faster onset

OrganiGram Holdings Inc.'s market share leadership in Canada spans several product categories, indicating broad appeal across the recreational segment:

• Canada market share position: #1
• Market share in vapes: #1
• Market share in pre-rolls: #1
• Market share in milled flower: #1
• Market share in hash: #1
• Market share in pure CBD gummies: #1
• Market share in edibles: #3
• Market share in dried flower: #3

Finance: calculate the projected Q4 2025 international revenue based on the H2 2025 expectation by end of week.

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Cost Structure

You're looking at the core expenses that drive OrganiGram Holdings Inc.'s operations as of late 2025, based on their Q3 Fiscal 2025 results. Understanding these numbers is key to seeing where the money goes before revenue hits the bottom line.

The tax structure in Canada places a significant, non-operational cost burden on domestic sales. This is a fixed-rate drain on top-line revenue that you have to account for right away. Also, the cost to actually grow and process the product remains a major component of the overall spend.

Here's a quick look at the primary cost components from the third quarter ended June 30, 2025 (Q3 2025), with amounts in thousands of US dollars ($000s) unless otherwise noted:

Cost Category	Q3 Fiscal 2025 Amount	As Percentage of Metric
Gross Revenue	$110,205	N/A
Excise Taxes	($39,413)	35.8% of Gross Revenue
Net Revenue	$70,792	N/A
Cost of Sales (COGS)	$48,369	68.3% of Net Revenue
Selling, General & Administrative (SG&A) Expenses	$24,500	35% of Net Revenue

The high excise tax burden, approximately 35.8% of gross revenue on domestic sales for Q3 2025, is a fixed cost that directly impacts the realized price per gram domestically. You see this clearly when comparing the $110.2 million in gross revenue to the $70.8 million in net revenue after that $39.4 million excise tax deduction.

The Cost of Goods Sold (COGS), reported as Cost of Sales, was $48,369 thousand in Q3 2025. This figure covers the direct costs for cultivation and manufacturing, and it represents a substantial 68.3% of the quarter's net revenue. Honestly, managing this cost is critical for margin improvement.

Selling, General, and Administrative (SG&A) expenses were $24.5 million in Q3 2025. As a proportion of net revenue, this totaled 35%, remaining flat compared to the prior year period. This SG&A spend includes investments in operational infrastructure.

You can see specific elements driving the SG&A increase:

• Incremental investment into the ERP system was $1.2 million higher than the prior year in Q3 2025.
• Higher amortization costs of $1.6 million related to the Motif and Collective Project acquisitions were also included in SG&A.

OrganiGram Holdings Inc. continues to make Capital Expenditures and strategic investments that fall outside of routine operating costs. For instance, the acquisition of Collective Project Limited (CPL) involved upfront consideration of approximately $6 million, plus potential milestone and earnout payments totaling up to $24 million.

The commitment to Research and Development (R&D) is largely channeled through the Product Development Collaboration (PDC) with British American Tobacco (BAT). This strategic funding mechanism has provided over $345 million in funding between 2021 and 2025, earmarked for onsite research focused on next-generation, non-combustible formats. This investment directly supports the development of new product formats, such as the FAST™ nanoemulsion technology for ingestibles.

Finance: draft 13-week cash view by Friday.

OrganiGram Holdings Inc. (OGI) - Canvas Business Model: Revenue Streams

You're looking at the specific ways OrganiGram Holdings Inc. (OGI) is bringing in money as of late 2025, based on their latest reported figures.

The primary engine for revenue remains the Canadian market, specifically the wholesale of recreational cannabis to provincial boards. This segment drove a record C$70.8 million in Q3 net revenue for Fiscal 2025. This figure represents a 72% year-over-year increase in net revenue for the quarter. The Canadian adult-use market accounted for 85% of that Q3 net revenue, equating to $59.9 million.

International wholesale revenue is a rapidly growing component of the stream. This segment surged 208% year-over-year to reach C$7.4 million in Q3 2025. This international portion represented about 10% of the total Q3 net revenue.

OrganiGram Holdings Inc. is also heavily focused on sales of high-margin, ready-to-consume products. They hold the #1 market share position in Canada for vapes and pre-rolls as of Q3 2025, indicating strong consumer pull in these value-added categories. Other revenues, which would include some of these premium products, accounted for $3.5 million, or 5% of Q3 net revenue.

A newer, yet strategically important, revenue source is from U.S. hemp-derived THC beverage sales, which began in Q3 2025 following the acquisition of Collective Project Ltd. The company launched its U.S. direct-to-consumer website, expanding availability to 25 states subsequent to the quarter end.

The operational performance supporting these revenue streams is reflected in the profitability metrics. Adjusted EBITDA reached C$5.7 million in Q3 2025, showing operating profitability for the core business. This was a 64% increase year-over-year.

Here is a breakdown of the Q3 Fiscal 2025 Net Revenue composition:

Revenue Source	Q3 2025 Amount (C$)	Percentage of Net Revenue
Recreational Cannabis Wholesale (Canada)	$59.9 million	85%
International Wholesale Revenue	$7.4 million	10%
Other Revenues (Including High-Margin Products)	$3.5 million	5%

The key drivers contributing to the top-line performance include:

• Record Net Revenue of C$70.8 million in Q3 2025.
• International sales growth of 208% year-over-year.
• Positive Free Cash Flow generation of $5.0 million in Q3 2025.
• Market leadership in key categories like vapes and pre-rolls.
• Synergies from the Motif acquisition contributing to margin improvement.